{"url":"https://lda.senate.gov/api/v1/filings/2d44112e-e835-4476-b240-60d933ec5fd8/","filing_uuid":"2d44112e-e835-4476-b240-60d933ec5fd8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2d44112e-e835-4476-b240-60d933ec5fd8/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jon R Wadsworth","dt_posted":"2025-08-11T12:45:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1242 E St NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":401100069,"url":"https://lda.senate.gov/api/v1/registrants/401100069/","house_registrant_id":null,"name":"ATLAS ADVOCACY","description":"disinfectant manufacturing","address_1":"1242 E St NE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JON WADSWORTH","contact_telephone":"+1 202-320-4888","dt_updated":"2026-06-09T13:01:01.140854-04:00"},"client":{"id":211544,"url":"https://lda.senate.gov/api/v1/clients/211544/","client_id":101,"name":"BRIOTECH INC","general_description":"Disinfectant Manufacturing","client_government_entity":false,"client_self_select":null,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"FDA requirements","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69124,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":"ROBINSON","last_name":"WADSWORTH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58980,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":"Sen Dan Coates/ EOP/ Dept. of VA","new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}